At a glance
ClinicalIndex Comparison RecordN/ACompleted· 57 enrolled
Drug / intervention
Tablet-based questionnairedevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Pilot Study for Tablet-based Questionnaire of Patient-reported Outcomes From Patients Undergoing Chemotherapy (TabPRO I)
In Brief
A clinical study evaluating Tablet-based questionnaire for Antineoplastic Agents. Completed, enrolled 57 participants across 3 sites.
Detailed Summary
This study is a single arm feasibility study. Patients that have been diagnosed with carcinoma and are undergoing chemotherapy have to document chemotherapy associated side effects on a regular basis by means of a tablet-based online questionnaire. Goal of the study is to find out if patients that are undergoing chemotherapy are willing to document chemotherapy associated side effects by means of a tablet-based online questionnaire.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAntineoplastic Agents
CountriesGermany
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
Enrollment StartSep 2013
First PostedNov 2013
Primary CompletionDec 2015
TodayJul 2026
First PostedNov 25, 2013
Enrollment StartSep 1, 2013
Primary CompletionDec 1, 2015
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 12.6 years ago
Interventions
Tablet-based questionnairedevice
tablet-based patient reported outcomes (TabPRO)